savepiginvest

PCI Biotech $PCIB.OL testing breakout from yearlong downtrend

Pembelian
OSL:PCIB   PCI BIOTECH HOLDING ASA
PCI Biotech Holding PCIB stock has been consolidating in a trading range below last years 30 NOK shareprice rights issue of NOK 360 million.


Positive market reaction to the latest quarterly report from the company, along with good coverage in magasines:

https://www.tu.no/artikler/selskapet-bruker-lys-i-behandling-av-kreft/472385 (norwegian language)

https://nordiclifescience.org/wp-content/public_html/2019/08/NL-nr-3-2019_150-dpi_uppslag.pdf (page 91-94)

At the moment, the stock is testing a breakout from the old trading range, and longs will be keen to see further conference or scientific journal coverage of the ongoing clinical programs for the companys FimaCHEM and FimaVACC products, as well as partnering deals for its FimaNAC product.
Trade aktif:
First test not looking to bright this monday, and stock is trading right above stop level
Trading ditutup: stop tercapai:
Stopped out of this trade, better luck next time!

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.